Hycamtin (Hy-CAM-tin, topotecan) for ovarian cancer

SmithKline Beecham is introducing Hycamtin (Hy-CAM-tin, topotecan) for ovarian cancer.

Hycamtin is the first in a new class called camptothecins...or topoisomerase I inhibitors. Blocking this enzyme leads to DNA damage when cells replicate.

Hycamtin will be used as second-line therapy for advanced ovarian cancer...usually after treatment with cisplatin or Taxol.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote